Got Approval… Now What? Meeting Cell Therapy Market Demand
Panelists Ken Kotz from bluebird bio, Isaac Erickson from DiscGenics, Greg Bonfiglio from Proteus, LLC and Invetech's David Hodl share their vision for commercial manufacturing of cell therapies.
The commercial success of a cell-based therapeutic depends on a scalable, automated manufacturing process. But how can companies ensure their manufacturing processes are up to meeting the needs and market demand of the rapidly evolving cell therapy field? Our annual breakfast briefing at the Phacilitate Leaders World conference 2020 in Miami tackled this and other current topics.